POONGJEON PHARMACY CO.,LTD. · 증권발행결과(자율공시) (제3자배정 유상증자)
Securities Issuance Results (Voluntary Disclosure)
| 1. Type of Securities | Common Stock | |
| 2. Issuance Method | Paid-in capital increase via third-party allotment3 | |
| 3. Issuance Details | Shares to Be Issued (shares) | 1,200,000 |
| Planned Issuance Amount (KRW) | 3,000,000,000 | |
| Initial Board Resolution Date for Issuance | 2026-10-26 | |
| Actual Shares Issued (shares) | 1,200,000 | |
| Actual Issuance Amount (KRW) | 3,000,000,000 | |
| Payment Date | 2026-11-10 | |
| 4. Listing Planned | Yes | |
| 5. Other Matters Relevant to Investment Decisions | - 본 유상증자로 발행되는 신주는 1년간 한국예탁결제원에 보호예수 될 예정입니다 | |
| ※ Related Disclosures | 2026-10-26 유상증자결정(제3자배정) | |